Companies developing peptide drug delivery technologies, including formulation development, encapsulation, and controlled-release systems. Peptide drug delivery faces pharmaceutical challenges including enzymatic degradation in the GI tract, poor oral bioavailability, and short plasma half-lives. Common delivery approaches include lipid-based nanoparticles, polymeric microspheres for sustained release, transdermal microneedle patches, and subcutaneous depot formulations using PLGA encapsulation. GLP-1 receptor agonist programs have driven significant innovation in once-weekly and once-monthly peptide delivery systems to improve patient compliance and reduce injection burden. Showing 3 listed suppliers.
Our directory lists suppliers offering drug delivery services across Europe, North America regions. Supplier types include Chemical Supplier, CDMO. Browse individual profiles below for detailed capability information, manufacturing standards, and quality documentation.
Directory listing last reviewed July 2026.